166 related articles for article (PubMed ID: 17242769)
1. [Systemic lupus erythematosus: cutaneous/articular injuries].
Sociedade Brasileira de Reumatologia
Rev Assoc Med Bras (1992); 2006; 52(6):384-6. PubMed ID: 17242769
[No Abstract] [Full Text] [Related]
2. A review of the evidence and cost of therapies for cutaneous lupus erythematosus.
Rosen JD; Paul S; Maderal A
Lupus; 2019 Jun; 28(7):799-805. PubMed ID: 31042129
[TBL] [Abstract][Full Text] [Related]
3. [Antimalarials in lupus erythematosus treatment].
Woźniacka A
Przegl Lek; 2002; 59(3):179-82. PubMed ID: 12184034
[TBL] [Abstract][Full Text] [Related]
4. Innovative management of lupus erythematosus.
Knott HM; Martínez JD
Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
[TBL] [Abstract][Full Text] [Related]
5. Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus.
Udompanich S; Chanprapaph K; Suchonwanit P
Am J Clin Dermatol; 2018 Oct; 19(5):679-694. PubMed ID: 29948959
[TBL] [Abstract][Full Text] [Related]
6. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
[TBL] [Abstract][Full Text] [Related]
7. Treatment of systemic lupus erythematosus - 2013 update.
Belmont HM
Bull Hosp Jt Dis (2013); 2013; 71(3):208-13. PubMed ID: 24151947
[TBL] [Abstract][Full Text] [Related]
8. [Skin manifestations of lupus erythematosus].
Harr T; Bircher AJ; Häusermann P
Ther Umsch; 2005 May; 62(5):303-12. PubMed ID: 15945221
[TBL] [Abstract][Full Text] [Related]
9. Antimalarial resistance in lupus: a lesser-explored terrain.
Bishnoi A; Vinay K; Handa S
Lupus; 2019 Jan; 28(1):145-146. PubMed ID: 30472916
[No Abstract] [Full Text] [Related]
10. Treatment of cutaneous lesions in patients with lupus erythematosus.
Callen JP
Dermatol Clin; 1990 Apr; 8(2):355-65. PubMed ID: 2191806
[TBL] [Abstract][Full Text] [Related]
11. Management of "refractory" skin disease in patients with lupus erythematosus.
Callen JP
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):767-84. PubMed ID: 16150402
[TBL] [Abstract][Full Text] [Related]
12. Update on the management of cutaneous lupus erythematosus.
Callen JP
Br J Dermatol; 2004 Oct; 151(4):731-6. PubMed ID: 15491411
[TBL] [Abstract][Full Text] [Related]
13. Plaque-like Cutaneous Lupus Mucinosis as the First Sign of Systemic Lupus Erythematosus.
Gao M; Sheng N; Yang X; Jiang Y
Acta Derm Venereol; 2020 Feb; 100(4):adv00048. PubMed ID: 31774542
[No Abstract] [Full Text] [Related]
14. Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review.
Chasset F; Francès C
Drugs; 2019 Jul; 79(11):1199-1215. PubMed ID: 31228033
[TBL] [Abstract][Full Text] [Related]
15. Manifestations and treatment of cutaneous lupus erythematosus (part I of II).
Schairer D; Friedman A
J Drugs Dermatol; 2011 Oct; 10(10):1212-4. PubMed ID: 21968677
[No Abstract] [Full Text] [Related]
16. Management of cutaneous lupus erythematosus.
Tuffanelli DL
Clin Dermatol; 1985; 3(3):123-30. PubMed ID: 3880020
[No Abstract] [Full Text] [Related]
17. The history of antimalarials.
Wallace DJ
Lupus; 1996 Jun; 5 Suppl 1():S2-3. PubMed ID: 8803902
[No Abstract] [Full Text] [Related]
18. [What's new in internal medicine?].
Bessis D
Ann Dermatol Venereol; 2012 Dec; 139 Suppl 5():S194-201. PubMed ID: 23522706
[TBL] [Abstract][Full Text] [Related]
19. The different faces of cutaneous lupus erythematosus.
Renner R; Sticherling M
G Ital Dermatol Venereol; 2009 Apr; 144(2):135-47. PubMed ID: 19357621
[TBL] [Abstract][Full Text] [Related]
20. Lupus erythematosus and lupus valgaris: a case report and historical remarks.
Ye S; Yang CD
Clin Rheumatol; 2007 Jan; 26(1):120-1. PubMed ID: 16429241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
